Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: HEMOGLOBIN OXYGEN THERAPEUTICS LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-06-01 to 2029-05-31
Current total value of award: $12534579
Description: CANINE OXYGEN CARRIER MANUFACTURING RESTORATION AND REGULATORY ACTIVITIES